drugset / Trial / NCT02012777

Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease

NCT02012777

Phase 1 Terminated 9 enrolled University of Miami Duke University · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Propanolol is a beta blocker which has been found to inhibit the ability of epinephrine to upregulate sickle red cell adhesion to laminin and endothelial cells in vitro. The purpose of this pilot study is to administer one dose of propanolol to children with sickle cell disease and to measure pre and post dose red cell adhesion. The hypothesis is that a single dose of propanolol will decrease red cell adhesion to laminin and endothelial cells as compared to baseline.

Timeline

Start
2010-06
Primary completion
2012-11
Completion
2013-04-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propranolol Small molecule 10 mg
Comparator Propranolol Small molecule 20 mg
Comparator Propranolol Small molecule 40 mg

Indications